PETER 

 

FLYNN, PH.D. 

EXECUTIVE OFFICER, DIRECTOR

ARIALYS THERAPEUTICS, INC.

ED 

 

HURWITZ 

DIRECTOR

CALISTOGA PHARMACEUTICALS INC   |  SUNESIS PHARMACEUTICALS INC   |  TALIGEN THERAPEUTICS INC   |  CARA THERAPEUTICS INC   |  MACROGENICS INC   |  VIEWPOINT THERAPEUTICS, INC.   |  REKINDLE THERAPEUTICS INC.   |  BIOINTERVENE, INC.   |  ARIALYS THERAPEUTICS, INC.

JAY 

 

LICHTER, PH.D. 

EXECUTIVE OFFICER, DIRECTOR

REVISION THERAPEUTICS, INC.   |  OTONOMY, INC.   |  ARATANA THERAPEUTICS, INC.   |  JANUX THERAPEUTICS, INC.   |  NERIO THERAPEUTICS, INC.   |  ARIALYS THERAPEUTICS, INC.

TIGHE 

 

REARDON 

EXECUTIVE OFFICER

AVALON VENTURES XI, L.P.   |  ARISTAMD, INC.   |  SYNTHORX, INC.   |  CELLULAR APPROACHES, INC.   |  JANUX THERAPEUTICS, INC.   |  NERIO THERAPEUTICS, INC.   |  ANKASA REGENERATIVE THERAPEUTICS, INC.   |  AVALON BIOVENTURES SPV I, L.P.   |  ENLAZA THERAPEUTICS, INC.   |  AVALON BIOVENTURES SPV II, L.P.   |  ARIALYS THERAPEUTICS, INC.   |  AERORX THERAPEUTICS, INC.

BRIAN 

 

SLINGSBY, M.D., PH.D., M.P.H. 

DIRECTOR

ARIALYS THERAPEUTICS, INC.

ASHISH 

 

XAVIER, PH.D. 

DIRECTOR

ARIALYS THERAPEUTICS, INC.